Christian Graves

Christian Graves is co-founder and chairman of the Carolina Biotech Group.  Currently pursing a path as a physician-scientist at USC School of Medicine, Graves is passionate about translating discoveries at the bench into meaningful therapies that benefit others.  He is a South Carolinian through-and-through (just lacks the accent) and is proud to have returned to his roots after fellowship at the National Institutes of Health where he successfully pursued translational medicine with a focus in all things neuro.  He thrives when working with diverse teams of innovators to improve health, rebels against traditional barriers to progress, and would like to see himself as a pioneer.  He enjoys spending time in the mountains with his family rock climbing, biking, and whitewater kayaking, renovating his mid-century house, and rooting for his local hockey team.

Dr. Stephen Iwanowycz

Stephen is a board member and the co-founder of CBG.  He studies macrophages, perhaps the most complicated cellular compartment in our bodies. His research focuses on the pursuit of strategies to improve the function of the immune system in disease. Realizing a need for entrepreneurial education later in his training, he assembled the nucleus of what is today CBG.   As an elite USC Presidential Fellow and in interacting with other entrepreneurial leaders, he realized he was much better suited for a translational research career path. Stephen carries the passion of promoting the local biotechnology space in SC and educating tomorrow’s leaders.  He hopes to build pipelines for our best and brightest to find their best jobs SC while endeavoring to create first in class diagnostics and therapeutics with other entrepreneurial scientists. When not pursuing his hobby of being in the lab, Stephen emphasizes his family above all else.  He is happily married to his wife Trisha and they have a young son Matthias.

Kayla Wilson

Kayla is a member of the board, a biotech startup officer, and a graduate student at Clemson University.  She never saw herself pursuing the business of science.  However, she has quickly broken through and helped to co-found a low cost diagnostics business, Accessible Diagnostics.  Currently the CTO, Wilson has a chip on her shoulder when it comes to disrupting access to glucose testing, a global market that exceeds 236 Mil underserved.  Synergizing accessible printing technologies with a smartphone-based app, she is helping fulfill the dream that millions will one day have better endocrinologic control of their diabetes. When not in the lab, mentoring emerging leaders through the Creative Inquiry program, or competing in the nation’s top design competitions, Wilson spends her time traveling the world to places like Tanzania meeting with physicians, scientists, and healthcare advocates.  In her spare time, she enjoys spending time with her husband Torynce with their fur-baby (insert name).  Kayla is an avid wood-worker, enjoys exploring her culinary passions through dinner parties, and getting after it with her roller derby team.

David Prim

David is a biomedical engineer with an eye toward business. He is currently pursuing his PhD in biomedical engineering at the University of South Carolina, where he also received his B.S. in biomedical engineering through the South Carolina Honors College. David aspires to apply his diverse skillset towards helping disruptive biomedical technologies grow and prosper. When David is not pursuing new professional and academic challenges, he can be found spending time with his wife, Rosanne, and his two dogs, Beauregard and Wheatley. At home, David enjoys cooking and tackling home improvement projects. Additionally, he is a soccer fanatic and makes time to play at the amateur level and volunteer for the River Bluff High School boys' soccer program, where he is the goalkeeper trainer.

Dr. Ehsan Jabbarzadeh

Dr. Jabbarzadeh is a Faculty member in the College of Engineering at the University of South Carolina. His credentials include a PhD in chemical engineering from Drexel University, a three-year Postdoctoral Fellowship in bioengineering from California Institute of Technology, and an MBA in finance and entrepreneurship from USC-Marshall School of Business. Dr. Jabbarzadeh’s scientific research interests include regenerative medicine, stem cells and tissue engineering. He serves as an adviser to a number of investors combining his expertise in life sciences and financial modeling to assess the idiosyncratic risks and the probabilities of success for companies in biotech/pharma space. Dr. Jabbarzadeh’s passion is to partner with young entrepreneurs to catalyze the development and commercialization of transformative technologies.